Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
34
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Storytel
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding Global Markets Will Unlock Scalable Audio Subscriptions
Key Takeaways Accelerating international subscriber growth and content personalization are reducing churn and fueling scalable, recurring revenue with improved margins. Strategic expansion into new markets, strong cash generation, and synergetic acquisitions support sustained growth and earnings diversification.
View narrative
SEK 126.50
FV
30.2% undervalued
intrinsic discount
9.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 days ago
author updated this narrative
AdaptHealth
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Capitated Deal And AI Automation Will Transform Home Healthcare
Key Takeaways Exclusive long-term contracts, digital automation, and demographic tailwinds are enhancing recurring revenue, operational efficiency, and providing sustained growth opportunities in core segments. Industry consolidation, margin expansion, and improved financial flexibility through disciplined M&A and debt reduction strengthen competitive positioning and long-term earnings potential.
View narrative
US$13.13
FV
26.8% undervalued
intrinsic discount
7.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
10 days ago
author updated this narrative
Harvard Bioscience
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Demographic Shifts And NIH Funding Will Unlock Biomedical Potential
Key Takeaways Strong alignment with biomedical research trends and expanding proprietary technology platforms positions the company well for sustained growth and margin improvement. Enhanced operational efficiency and capital restructuring increase financial flexibility, supporting continued investment in innovation and long-term profitability.
View narrative
US$3.00
FV
83.7% undervalued
intrinsic discount
1.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
10 days ago
author updated this narrative
Yubico
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Subscription Shift And Cybersecurity Trends Will Strengthen Future Position
Key Takeaways Transition to subscription-based sales and broader identity solutions positions Yubico for stronger margins, recurring revenue, and increased customer retention. Escalating demand from regulation and cyber threats, combined with early penetration in large enterprises, provides a runway for sustained market and earnings growth.
View narrative
SEK 155.75
FV
9.8% undervalued
intrinsic discount
14.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
4 days ago
author updated this narrative
Alnylam Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 30 Analysts
RNAi Therapies Will Ensure Worldwide Market Expansion
Key Takeaways Growing market adoption and global expansion of core RNAi therapies, alongside efficient payer access, are driving sustained revenue growth and operational leverage. Advancing pipeline assets and leadership in rare disease innovation position the company to benefit from ongoing healthcare sector trends and precision medicine expansion.
View narrative
US$424.64
FV
7.0% overvalued
intrinsic discount
41.73%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
5 days ago
author updated this narrative
Allegiant Travel
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Value Travel And Fleet Renewal Will Strengthen Future Prospects
Key Takeaways Strategic focus on budget travel, efficient routes, and ancillary services is likely to drive sustained passenger growth and profitability. Fleet modernization and streamlined operations enhance efficiency, reduce costs, and allow redeployment of capital to strengthen financial stability.
View narrative
US$60.92
FV
0.5% undervalued
intrinsic discount
5.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
10 days ago
author updated this narrative
Medical Developments International
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Targeted Pricing And Penthrox Expansion Will Broaden International Reach
Key Takeaways Targeted pricing and efficiency programs are improving margins, expected to enhance earnings and net margins over the next few years. Growth in Penthrox volumes, regulatory approvals, and partner-supported models aim to boost revenue in key markets.
View narrative
AU$2.32
FV
72.6% undervalued
intrinsic discount
14.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
10 days ago
author updated this narrative
Pepco Group
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Expansion In Central And Eastern Europe Will Unlock Future Potential
Key Takeaways Expansion in Central and Eastern Europe and focus on value are driving increased sales, supported by demographic trends and consumer behavior. Operational improvements and digital initiatives are enhancing margins, customer engagement, and efficiency, strengthening prospects for sustained earnings growth.
View narrative
zł24.27
FV
10.1% undervalued
intrinsic discount
-2.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
10 days ago
author updated this narrative
Pureprofile
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
AI And Automation Will Capture US And UK Markets
Key Takeaways Expansion into global markets and investment in AI-driven platforms position Pureprofile for scalable growth and reduced regional risk. Emphasis on first-party, privacy-compliant data and successful acquisitions strengthen competitiveness and support recurring revenue expansion.
View narrative
AU$0.12
FV
65.0% undervalued
intrinsic discount
14.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
10 days ago
author updated this narrative
Value any company in seconds
Popular companies